American Society of Clinical Oncology - Clinical Cancer Advances 2017

Checkpoint Inhibitors work well Against Hypermutated Cancers Voltar

-

Advance of the Year: Immunotherapy 2.0 - -

Artigo Autor(es) Referência
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Kaufman Howard L, Russell Jeffery, Hamid Omid, Bhatia Shailender, Terheyden Patrick, D'Angelo Sandra P, Shih Kent C, Lebbé Céleste, Linette Gerald P, Milella Michele, Brownell Isaac, Lewis Karl D, Lorch Jochen H, Chin Kevin, Mahnke Lisa, von Heydebreck Anja, Cuillerot Jean-Marie, Nghiem Paul The Lancet. Oncology. 2016 Oct; 17(Oct):1374-1385. doi: 10.1016/S1470-2045(16)30364-3. pii: S1470-2045(16)30364-3.
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency. Bouffet Eric, Larouche Valérie, Campbell Brittany B, Merico Daniele, de Borja Richard, Aronson Melyssa, Durno Carol, Krueger Joerg, Cabric Vanja, Ramaswamy Vijay, Zhukova Nataliya, Mason Gary, Farah Roula, Afzal Samina, Yalon Michal, Rechavi Gideon, Magimairajan Vanan, Walsh Michael F, Constantini Shlomi, Dvir Rina, Elhasid Ronit, Reddy Alyssa, Osborn Michael, Sullivan Michael, Hansford Jordan, Dodgshun Andrew, Klauber-Demore Nancy, Peterson Lindsay, Patel Sunil, Lindhorst Scott, Atkinson Jeffrey, Cohen Zane, Laframboise Rachel, Dirks Peter, Taylor Michael, Malkin David, Albrecht Steffen, Dudley Roy W R, Jabado Nada, Hawkins Cynthia E, Shlien Adam, Tabori Uri Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 07; 34(07):2206-11. doi: 10.1200/JCO.2016.66.6552. pii: .
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. Le Dung T, Uram Jennifer N, Wang Hao, Bartlett Bjarne R, Kemberling Holly, Eyring Aleksandra D, Skora Andrew D, Luber Brandon S, Azad Nilofer S, Laheru Dan, Biedrzycki Barbara, Donehower Ross C, Zaheer Atif, Fisher George A, Crocenzi Todd S, Lee James J, Duffy Steven M, Goldberg Richard M, de la Chapelle Albert, Koshiji Minori, Bhaijee Feriyl, Huebner Thomas, Hruban Ralph H, Wood Laura D, Cuka Nathan, Pardoll Drew M, Papadopoulos Nickolas, Kinzler Kenneth W, Zhou Shibin, Cornish Toby C, Taube Janis M, Anders Robert A, Eshleman James R, Vogelstein Bert, Diaz Luis A The New England journal of medicine. 2015 Jun; 372(Jun):2509-20. doi: 10.1056/NEJMoa1500596. pii: .
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. Nghiem Paul T, Bhatia Shailender, Lipson Evan J, Kudchadkar Ragini R, Miller Natalie J, Annamalai Lakshmanan, Berry Sneha, Chartash Elliot K, Daud Adil, Fling Steven P, Friedlander Philip A, Kluger Harriet M, Kohrt Holbrook E, Lundgren Lisa, Margolin Kim, Mitchell Alan, Olencki Thomas, Pardoll Drew M, Reddy Sunil A, Shantha Erica M, Sharfman William H, Sharon Elad, Shemanski Lynn R, Shinohara Michi M, Sunshine Joel C, Taube Janis M, Thompson John A, Townson Steven M, Yearley Jennifer H, Topalian Suzanne L, Cheever Martin A The New England journal of medicine. 2016 Jun; 374(Jun):2542-52. doi: 10.1056/NEJMoa1603702. pii: .
Nenhuma revista foi definida para este congresso.